| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.39 | 8e-14 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.26 | 6e-09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.27 | 7e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.25 | 3e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.25 | 5e-07 |